Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: Efficacy and safety outcomes of a randomized, multi-center phase II study investigating
2014 ◽
Vol 110
(1)
◽
pp. 126-131
◽
2008 ◽
Vol 72
(1)
◽
pp. S38
◽